The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Too often, BPC 157 gets boxed into a single use: injury recovery. Gabriel Alizaidy, MD, MS BPC 157 has generated significant research attention, but most of it is happening in animal models. Here's what 47 trials and 100+ studies actually reveal: an enormous gap between preclinical promise and human Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review